Peptide research, without the hype.
Plain-language, source-backed summaries of what the studies actually say. Every finding tagged human or animal. Four languages, no selling.
Last updated:
Recent updates
FDA expands Imcivree to acquired hypothalamic obesity (ages 4+)
Boehringer Ingelheim files NDA for survodutide (obesity)
Source-backed, plain-language articles on the peptides researchers and the public are most curious about. Every study labeled human or animal. Pick a category to dive in.
Browse by category
Weight-Loss Peptides
GLP-1s, dual/triple agonists, MC4R agonists and pipeline drugs — from semaglutide to retatrutide.
Healing & Recovery
Soft-tissue repair, wound healing and anti-inflammatory peptides like BPC-157 and TB-500.
Growth Hormone & IGF-1
GHRH analogs, GHRP family, ghrelin mimetics and IGF-1 variants — ipamorelin, CJC-1295, MK-677.
Cognitive & Sleep
Peptides targeting cognition, mood, anxiety and sleep — Selank, Semax, DSIP, Cerebrolysin.
Immune & Antimicrobial
Immune-modulating and antimicrobial peptides — Thymosin alpha-1, LL-37, KPV.
Longevity & Anti-Aging
Peptides marketed for longevity — Epitalon, MOTS-c, MK-677. Hype versus evidence.
Hormonal & Reproductive
Reproductive axis and neurohormonal peptides — kisspeptin, PT-141, oxytocin, melanotan-II.